5353 new20logo 01 4

Iron-Deficiency-Anemia-Market-Insights-01

 

The Iron Deficiency Anemia Market Report from DelveInsight provides an in-depth understanding of Iron Deficiency Anemia, historical and forecasted epidemiology, as well as Iron Deficiency Anemia market patterns in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Some of the Key Highlights from the Iron Deficiency Anemia Market Report

  • The US population was analysed between 1999 and 2018, and dietary iron consumption decreased by 6.6 percent and 9.5 percent for male and female adults, respectively, according to Sun and Wiever (2021). The incidence of estimated anemia increased by 10.5 percent to 10.6 percent in the United States, based on age and gender.
  • According to Warner and Kamran (2020), 1 percent of men under 50 in the United States have Iron Deficiency Anemia. In the United States, ten percent of women of childbearing age are Iron deficient due to menstrual losses, whereas nine percent of children aged 12 to 36 months are iron deficient, with one-third of these children developing anemia.
  • Pipeline therapies in the Iron Deficiency Anemia market are Vadadustat (Akebia Therapeutics), Daprodustat (GlaxoSmithKline), IHAT-02 (Nemysis), MPB-1514 (MegaPro Biomedical), and others.
  • Akebia Therapeutics, GlaxoSmithKline, Nemysis, MegaPro Biomedical, among others are the major players in the Iron Deficiency Anemia market.
  • The rise in Iron Deficiency Anemia market size is a direct result of the increase in the 7MM  Iron Deficiency Anemia cases. 
  • The  Iron Deficiency Anemia therapeutic market is expected to expand as disease understanding improves and new therapies enter the market.

Request sample @ Iron Deficiency Anemia Market Insights

Current clinical practices, new medications, Iron Deficiency Anemia market share of individual therapies, current and forecasted Iron Deficiency Anemia market Size from 2018 to 2030 segmented by seven major markets are all covered in the Iron Deficiency Anemia market report.

Iron Deficiency Anemia: Disease Overview

Anaemia occurs when the number of red blood cells or the concentration of haemoglobin is lower than average. Men over 15 years of age have haemoglobin (Hb) concentrations below 13 g/dl, non-pregnant women over 15 years of age have Hb concentrations below 12 g/dl, and pregnant women have Hb concentrations below 11 g/dl. There would be a reduced capacity of the blood to bring oxygen to the body’s tissues whether there are too few or abnormal red blood cells, or not enough haemoglobin.

Iron Deficiency Anemia Epidemiology Segmentation

  • Anemia Total Prevalent Cases
  • Anemia Gender-Specific Cases
  • Anemia Age-Specific Cases
  • Anemia Severity-Specific Cases
  • Anemia Total Diagnosed and Treated Cases

Learn more about epidemiology @ Iron Deficiency Anemia Epidemiology

Iron Deficiency Anemia Treatment Landscape

The aim of treatment is to get Hb levels and red cell indices back to normal, as well as replenish iron reserves. Some of the current treatment options for Iron Deficiency Anemia are:

  • Ferrous sulfate
  • Ferric citrate (Auryxia)
  • Ferric carboxymaltose injection (Injectafer)
  • Ferric derisomaltose (Monoferric)

 

Iron Deficiency Anemia Market

Key pharmaceutical companies such as Akebia Therapeutics, GlaxoSmithKline, Nemysis, MegaPro Biomedical, and others are expected to launch new therapies in the Iron Deficiency Anemia market.

The introduction of Vadadustat (Akebia Therapeutics), Daprodustat (GlaxoSmithKline), IHAT-02 (Nemysis), MPB-1514 (MegaPro Biomedical) are expected to give the Iron Deficiency Anemia market a significant boost in the forecast period 2021-30 in the 7MM.

Iron Deficiency Anemia Pipeline Therapies and Key Companies

  • Vadadustat: Akebia Therapeutics
  • Daprodustat: GlaxoSmithKline
  • IHAT-02: Nemysis
  • MPB-1514: MegaPro Biomedical

Get more details about emerging drugs @ Iron Deficiency Anemia Pipeline Therapies and Major Companies

Table of Contents

1. Key Insights
2. Anemia : Market Overview at a Glance
3. Executive Summary
4. Organizations
5. Anemia : Patient Journey
6. Disease Overview: Anemia
7. Anemia : Epidemiology and Patient Population
8. Anemia : Unmet Needs
9. Anemia : Emerging Therapies
10. Anemia : Market Outlook
11. Anemia : Market Drivers
12. Anemia : Market Barriers
13. Anemia : Market access and Reimbursement
14. SWOT Analysis
15. Case studies
16. KOL Views
17. Appendix
18. Disclaimer
19. About DelveInsight

Know more about report offerings @ Iron Deficiency Anemia Market Outlook

Related Reports

Iron Overload Syndrome Market

DelveInsight’s “Iron Overload Syndrome – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Iron Overload Syndrome, historical and forecasted epidemiology as well as the Iron Overload Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Somatotropin Deficiency  Market

Get comprehensive historical and forecast analysis of Somatotropin Deficiency Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Merck Serono, Pfizer, Novo Nordisk, F. Hoffmann-La Roche, Eli Lilly, BioPartners, among others.

Vitamin A Deficiency Market

DelveInsight’s “Vitamin A Deficiency Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Vitamin A Deficiency , historical and forecasted epidemiology as well as the Vitamin A Deficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Adult Growth Hormone Deficiency Market

DelveInsight’s “Adult Growth Hormone Deficiency (AGHD) – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Adult Growth Hormone Deficiency (AGHD), historical and forecasted epidemiology as well as the Adult Growth Hormone Deficiency (AGHD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Alpha- Antitrypsin Deficiency Market

DelveInsight’s ‘Alpha- Antitrypsin Deficiency (AATD) – Market Insights, Epidemiology and Market Forecast-2028’ report delivers an in-depth understanding of the disease, historical and forecasted epidemiology trends in the United States and EU5 (Germany, Spain, Italy, France and United Kingdom).

Coagulation Factor Deficiency Market

Get comprehensive historical and forecast analysis of Coagulation Factor Deficiency Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Sanofi, Biotest, Hoffmann-La Roche, AryoGen Pharmed Co., ICON plc., among others.

Pyruvate Kinase Deficiency Market

DelveInsight’s “Pyruvate Kinase Deficiency- Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Pyruvate Kinase Deficiency , historical and forecasted epidemiology as well as the Pyruvate Kinase Deficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Irritable Bowel Syndrome Market 

Get comprehensive historical and forecast analysis of Irritable Bowel Syndrome Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Redhill Biopharma, Forest Pharmaceuticals, Inc., Bausch Health, among others.

Immunologic Deficiency Syndrome Market

DelveInsight’s “Immunologic Deficiency Syndrome- Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Immunologic Deficiency Syndrome, historical and forecasted epidemiology as well as the Immunologic Deficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Aneurysmal Subarachnoid Hemorrhage Market

Get comprehensive historical and forecast analysis of Aneurysmal Subarachnoid Hemorrhage Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Arbor Pharmaceuticals, Evgen Pharma, Idorsia Pharmaceuticals, Grace Therapeutics, Edge Therapeutics/PDS Biotechnology Corporation, BIT Pharma, among others.

Related Posts

Autoimmune Hemolytic Anemia Epidemiology Forecast

Beta Thalassemia Market

Multiple Myeloma Market 

Get in touch with our Business executive for Competitive Insights, M&A and Due Diligence Services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance. 

Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Contact Us 

Sandeep Joshi 

info@delveinsight.com 

+1(919)321-6187 

www.delveinsight.com

Connect With Us at:

LinkedIn | Facebook | Twitter

Tags: Iron Deficiency Anemia Companies, Iron Deficiency Anemia Drugs, Iron Deficiency Anemia Market, Iron Deficiency Anemia ICD10, Iron Deficiency Anemia Causes, Iron Deficiency Anemia Treatment, Iron Deficiency Anemia Symptoms, Iron Deficiency Anemia, anemia

See Campaign: https://www.delveinsight.com/
Contact Information:
Sandeep Joshi  info@delveinsight.com  +1(919)321-6187

Tags:
IPS, Reportedtimes, Menafn, Extended Distribution, iCN Internal Distribution, Research Newswire, English

image

Contact Information:

Sandeep Joshi 

info@delveinsight.com 

+1(919)321-6187